Home »
Academic Articles & Research Papers
Showing 8 of 8 academic articles
Nick Bansback, Mina Tadrous, Marie Paul Nisingizwe, Michael R Law et al. • BMJ Public Health
(2025)
Background The introduction of direct-acting antivirals (DAAs) has allowed countries to reduce the health and economic burden of hepatitis C virus (HCV). However, access to DAAs remains expensive and limited in many countries globally due t...
DOAJ
Open Access (DOAJ)
DOI: 10.1136/bmjph-2024-001340
William Rodriguez, Ileana M. Cristea • Viruses
(2026)
Persistent oncovirus infections account for 15–20% of the global cancer burden, driving multiple forms of human cancer. To maintain persistent infection and spread, oncoviruses drive alterations in host cell metabolism, immune signaling, an...
DOAJ
Open Access (DOAJ)
DOI: 10.3390/v18030288
Samara Griffin, Timothy Papaluca, Jacinta A Holmes, Bridget Reid et al. • Health & Justice
(2026)
Abstract Background The community corrections population in Australia shares similar risk factors for hepatitis C virus (HCV) infection with people incarcerated in prisons, but without access to prison-based testing and treatment. While hep...
DOAJ
Open Access (DOAJ)
DOI: 10.1186/s40352-026-00411-6
S Yu Milovanova, L V Lysenko (Kozlovskaya), L Yu Milovanova, N N Mrykhin et al. • Терапевтический архив
(2018)
Hepatitis C virus (HCV) is a global population problem due to its high prevalence, usually late diagnosis, the difficulties of treatment. In the prognosis of patients with HCV not only hepatic, but increasingly frequent of extrahepatic HCV ...
DOAJ
Open Access (DOAJ)
DOI: 10.26442/terarkh2018906112-120
Yuan Zhang, Ya Zhang, Jing Wang, Li Lin et al. • Journal of Health, Population and Nutrition
(2025)
Abstract Objective By conducting TORCH screening and risk assessment analysis on childbearing-age women in different regions of China, the aim is to provide reference for reducing adverse pregnancy outcomes and improving the health status o...
DOAJ
Open Access (DOAJ)
DOI: 10.1186/s41043-025-01084-x
Hui Jun Zhou, Jing Cao, Hui Shi, Nasheen Naidoo et al. • Frontiers in Public Health
(2021)
Background: Hepatitis C virus (HCV) genotype 1 is the most prevalent HCV infection in China. Sofosbuvir-based direct antiviral agent (DAA) regimens are the current mainstays of treatment. Sofosbuvir/velpatasvir (SOF/VEL) and sofosbuvir/ledi...
DOAJ
Open Access (DOAJ)
DOI: 10.3389/fpubh.2021.779215
Zelin Tian, Chen Xu, Peijun Yang, Zhibin Lin et al. • Frontiers in Immunology
(2022)
Hepatocellular carcinoma(HCC) is the sixth most common cancer in the world and is usually caused by viral hepatitis (HBV and HCV), alcoholic, and non-alcoholic fatty liver disease(NAFLD). Viral hepatitis accounts for 80% of HCC cases worldw...
DOAJ
Open Access (DOAJ)
DOI: 10.3389/fimmu.2022.984728
Mamun Al-Mahtab, Salimur Rahman, Fazal Karim, Graham Foster et al. • Bangabandhu Sheikh Mujib Medical University Journal
(2009)
Background: Hepatitis C virus is encountered sporadically in Bangladesh. It results in a wide range liver diseases, with asymptomatic acute hepatitis rarely at one end to HCC at the other end of the spectrum.
Methods: 1018 individuals of ...
DOAJ
Open Access (DOAJ)
DOI: 10.3329/bsmmuj.v2i1.3705